Chief, Infectious Disease Inpatient Services -- Midtown Campus
Associate Medical Director, Center for Infectious Diseases
725 West Lombard St. S320
Education and Training
Medical School- Georgetown University School of Medicine
Residency- Georgetown University Medical Center
Fellowship- Northwestern University School of Medicine
HIV, health care transition, adolescents and young adults, immunocompromised hosts
Ryscavage P, Anderson E, Sutton S, Reddy S, Taiwo, B. Clinical outcomes of adolescents and young adults in adult HIV care. J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):193-7.
Bhatia R, Ryscavage P, Taiwo B. Accelerated aging and human immunodeficiency virus infection: Emerging challenges of growing older in the era of successful antiretroviral therapy. J Neurovirol. 2012 Aug;18(4):247-55.
Yanik EL, Napravnik S, Ryscavage P, Eron JJ, Koletar SL, Moore RD, Zinski A, Cole SR, Hunt P, Crane HM, Kahn J, Mathews WC, Mayer K, Taiwo B. Hematologic, Hepatic, Renal and Lipid Laboratory Monitoring Following Initiation of Combination Antiretroviral Therapy in the United States, 2000-2010. J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):216-20.
Taiwo B, Yanik EL, Napravnik S, Ryscavage P, Koletar SL, Moore R, Mathews WC, Crane HM, Mayerr K, Zinski A, Kahn JS, Eron JJ. Evidence for risk-stratification when monitoring for toxicities following initiation of combination antiretroviral therapy. AIDS. 2013 Jun 19;27(10): 1593-602.
Taiwo B, Acosta EP, Ryscavage P, Berzins B, Lu D, Lalezari J, Castro J, Adeyemi O, Kuritzkes DR, Eron JJ, Tsibris A, Swindells S. Virologic Response, Early HIV-1 Decay and Maraviroc Pharmacokinetics with the Nucleos(t)ide-free Regimen of MaravIroc plus Darunavir/ritonavir in a Pilot Study. J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):167-173.
Ryscavage P, Taiwo B. Viral load diagnostics. HIV Specialist. 2013;5(3): 10-16.
Ryscavage P, Kelly S, Li JZ, Harrigan PR, Taiwo B. Significance and clinical management of persistent low-level viremia and very-low-level viremia in HIV-1-infected patients. Antimicrob Agents Chemother. 2014 Jul;58(7):3585-98.
Adejumo OA, Malee KM, Ryscavage P, Hunter SJ, Taiwo BO. Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review. J Int AIDS Soc. 2015 Sep 16;18(1):20049.
Taremi M, Kleinberg ME, Wang EW, Gilliam BL, Ryscavage PA. Galactomannan antigen detection using bronchial wash and bronchoalveolar lavage in patients with hematologic malignancies. Ann Clin Microbiol Antimicrob. 2015 Nov 14;14(1):50.
Ryscavage P, Macharia T, Patel D, Palmeiro R, Tepper V. Linkage to and retention in care following healthcare transition from pediatric to adult HIV care. AIDS Care. 2016 May;28(5):561-5.
Ryscavage P, Macharia T, Trinidad LR, Lovelace S, Tepper V, Redfield R. Patterns of Systemic Hypertension Among Adults With Perinatally Acquired HIV. J Int Assoc Provid AIDS Care. 2016, Sept 19 (Epub ahead of print).
Ryscavage P, Galvin S. Papular-Purpuric Gloves and Socks Syndrome: Case Report and Review. Infect Dis Clin Pract 2010;18: 128-131.
Berg N, Ryscavage P, Kulesza, P. The utility of fine needle aspiration for diagnosis of extrapulmonary coccidioidomycosis: a case report and discussion. Clinical Medicine & Research. 2011. 9(3): 130-133.
Ryscavage P, Noskin G, Bardowski L, Bobb A, Zembower T. Incidence and impact of false positive urine pneumococcal antigen screening in hospitalized patients. South Med J. 2011 Aug;104(8):593-7.
Dr. Ryscavage's research interests include HIV care and prevention, HIV health care transition, HIV care among young adults, and infectious diseases in immunocompromised hosts.
Dr. Ryscavage specializes in HIV/AIDS clinical care, HIV prevention, and infectious diseases in oncology patients.